These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Carcinoembryonic antigen as a prognostic indicator in the radiotherapeutic management of rectal cancer.
    Author: Davey P, Arnott SJ, Sturgeon CM.
    Journal: Eur J Surg Oncol; 1987 Feb; 13(1):17-20. PubMed ID: 2434361.
    Abstract:
    Carcinoembryonic antigen (CEA) levels have been assessed retrospectively in a group of 32 patients with inoperable or recurrent carcinoma of the rectum treated with radiotherapy. Complete clinical regression of pelvic disease was only achieved in patients with pre-treatment CEA levels less than 30 ng/ml when no metastases were present. Pre-treatment CEA assay has a place as a prognostic indicator in the radiotherapeutic management of inoperable or recurrent carcinoma of the rectum.
    [Abstract] [Full Text] [Related] [New Search]